CD40 and colitis: The treatment of anti‐CD40 colitis mice with I3C reduced the overall colitis as seen before with reversal of weight loss (Figure 6B), colon length (Figure 6C), macroscopic score (Figure 6D), and gut leakage as evidenced by decreased FITC‐dextran levels (Figure 6E).